Intech Investment Management LLC Buys 16,333 Shares of CME Group Inc. $CME

Intech Investment Management LLC increased its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 38.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 59,186 shares of the financial services provider’s stock after buying an additional 16,333 shares during the period. Intech Investment Management LLC’s holdings in CME Group were worth $16,313,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of CME. MJP Associates Inc. ADV acquired a new position in shares of CME Group in the second quarter valued at approximately $214,000. Cetera Investment Advisers lifted its holdings in CME Group by 3.6% during the 2nd quarter. Cetera Investment Advisers now owns 41,630 shares of the financial services provider’s stock worth $11,474,000 after purchasing an additional 1,434 shares during the last quarter. Creative Planning boosted its stake in CME Group by 4.7% in the 2nd quarter. Creative Planning now owns 77,734 shares of the financial services provider’s stock valued at $21,425,000 after purchasing an additional 3,464 shares during the period. SG Americas Securities LLC grew its holdings in CME Group by 893.9% in the 2nd quarter. SG Americas Securities LLC now owns 186,342 shares of the financial services provider’s stock valued at $51,360,000 after buying an additional 167,594 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in CME Group by 7.2% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 88,379 shares of the financial services provider’s stock valued at $24,359,000 after buying an additional 5,970 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction that occurred on Thursday, September 25th. The shares were acquired at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the purchase, the director directly owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This represents a 0.10% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 14,043 shares of company stock worth $3,791,486 over the last quarter. 0.30% of the stock is currently owned by company insiders.

CME Group Price Performance

Shares of NASDAQ:CME opened at $285.04 on Friday. The firm has a 50 day moving average of $267.33 and a 200-day moving average of $272.85. The stock has a market capitalization of $102.79 billion, a PE ratio of 27.62, a PEG ratio of 4.41 and a beta of 0.38. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12 month low of $222.56 and a 12 month high of $290.79.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the business posted $2.68 EPS. The firm’s revenue for the quarter was down 3.0% on a year-over-year basis. On average, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s payout ratio is 48.45%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CME. Deutsche Bank Aktiengesellschaft boosted their target price on shares of CME Group from $300.00 to $310.00 and gave the company a “buy” rating in a research report on Friday. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a report on Tuesday, October 14th. Morgan Stanley increased their target price on shares of CME Group from $312.00 to $314.00 and gave the stock an “overweight” rating in a research report on Thursday, October 23rd. Jefferies Financial Group dropped their price target on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research report on Friday, October 10th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $287.65.

Check Out Our Latest Stock Analysis on CME Group

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.